Virus News and Research

Latest Virus News and Research

GeoVax completes enrollment for HIV/AIDS vaccine Phase 2a clinical trial

GeoVax Labs, Inc., an Atlanta-based biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections, announced today the completion of enrollment for a Phase 2a clinical trial testing its HIV/AIDS vaccine.

3 Oct 2011

Bristol-Myers to present abstracts on research in liver disease at The Liver Meeting 2011

Bristol-Myers Squibb Company announced today that 22 abstracts on the Company's research in liver disease have been accepted for presentation at The Liver Meeting 2011, the 62nd annual meeting of the American Association for the Study of Liver Diseases, in San Francisco, November 4 - 8.

1 Oct 2011

Viewpoints: Sebelius on improving care; Samuelson on health costs; Durenberger on exporting U.S. system

Far too many Americans still go without the best care. That's why the Obama administration has joined with Truman Medical Centers and more than 2,500 other hospitals nationwide, along with thousands of employers, health insurers, provider organizations and patient advocates, to launch the Partnership for Patients … Over the next three years, we will reduce preventable injuries in hospitals by 40 percent. And we will cut hospital re-admissions by 20 percent, targeting the return trips that should never have occurred.

1 Oct 2011

New analyses from Phase III studies of VICTRELIS to be presented at AASLD 2011

Merck, known as MSD outside of the United States and Canada, announced today that several new analyses from Phase III studies of VICTRELIS (boceprevir), the company's first-in-class, oral hepatitis C virus NS3/4A protease inhibitor will be presented at the 62nd Annual Meeting of the American Association for the Study of Liver Diseases.

1 Oct 2011

Vertex announces abstracts from hepatitis C program to be presented at The Liver Meeting

Vertex Pharmaceuticals Incorporated today announced that abstracts from its hepatitis C program, including two late-breaking posters from studies of INCIVEK (telaprevir) tablets and VX-222, were accepted for presentation at The Liver Meeting, the 62nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in San Francisco, November 4-8, 2011.

1 Oct 2011

UCSF protein researcher wins NIH's Early Independence Award

James Fraser, PhD, a protein researcher who studies structural biology at the California Institute for Quantitative Biosciences (QB3) at the University of California, San Francisco (UCSF), is one of 10 recipients of a prestigious award for young scientists given for the first time by the National Institutes of Health.

1 Oct 2011

Patients with chronic hepatitis C less likely to take medications over time

Patients being treated for chronic hepatitis C become less likely to take their medications over time, according to a new study from the Perelman School of Medicine at the University of Pennsylvania.

30 Sep 2011

Researchers determine structure of RIG-I protein linked with viral infections

Researchers at Rutgers and UMDNJ-Robert Wood Johnson Medical School have determined the structure of a protein that is the first line of defense in fighting viral infections including influenza, hepatitis C, West Nile, rabies, and measles.

30 Sep 2011

Small Phase I trial shows HIV vaccine candidate is most powerful to date

Researchers at the Spanish Superior Scientific Research Council (CSIC) have successfully completed a small Phase I human clinical trial of an HIV vaccine candidate that granted 90 percent of 30 study participants an immunological response against the virus, Gizmag reports.

30 Sep 2011

Powerful HIV vaccine being tested on humans

Spanish researchers have developed a prototype of a vaccine against the AIDS-causing HIV virus that is “much more powerful” than those made to date.

29 Sep 2011

AASLD publishes updated practice guidelines on hepatitis C

On Monday, September 26, 2011, the American Association for the Study of Liver Diseases published online at its journal Hepatology's website an update to its practice guidelines for hepatitis C – "An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases."

29 Sep 2011

Viewpoints: Blocking, replacing health law; a doc's HPV advice; County wellness plan working

Too often, the Republican Party health-care agenda seems to consist of incanting "repeal and replace" and then to stop thinking - if the thinking ever begins at all. Certainly the current Presidential field is saying little beyond promising to repeal ObamaCare, but in the nick of time Paul Ryan has provided some intellectual guidance in an important speech yesterday at Stanford's Hoover Institution. he said "we cannot simply revert to the status quo."

29 Sep 2011

Phase I clinical trials reveal MVA-B preventive vaccine's immune efficiency against HIV

Phase I clinical trials developed by Spanish Superior Scientific Research Council (CSIC) together with Gregorio Mara--n Hospital in Madrid and Cl-nic Hospital in Barcelona, reveals MVA-B preventive vaccine's immune efficiency against Human's immunodeficiency virus (HIV).

28 Sep 2011

Long-term morbidity and mortality of NAFLD patients with advanced fibrosis, cirrhosis

Patients with non-alcoholic fatty liver disease (NAFLD) with advanced fibrosis or cirrhosis have a lower incidence of liver-related complications and hepatocellular carcinoma (HCC) than patients infected with hepatitis C virus (HCV), according to the prospective study published in the October issue of Hepatology, a journal of the American Association for the Study of Liver Diseases.

28 Sep 2011

Anthrax defenses need to be strengthened: Experts

It has been a decade since the anthrax attacks brought home the reality of bioterrorism and the nation now has a stockpile of some basic tools to fight back against a few of the threats that worry defense experts the most.

28 Sep 2011

Vietnam closes kindergartens to control outbreak of hand, foot and mouth disease

"More than a dozen kindergartens in Vietnam have closed to deal with an outbreak of hand, foot and mouth disease that has killed 111 children and sickened more than 57,000 this year, an official and the government said," according to the Associated Press/Washington Post.

28 Sep 2011

Treatment of CMV infection can inhibit medullablastomas development

Researchers at Karolinska Institutet in Sweden have demonstrated for the first time that it is possible to inhibit the growth of brain tumours by treating the common Cytomegalovirus (CMV). The virus, which is found in a wide range of tumour types, offers a possible route towards controlling tumour growth and reducing the size of the tumour as a complement to conventional cytotoxin-based therapies.

28 Sep 2011

New method for quickly identifying individual viruses

A new method for quickly identifying individual viruses and recognising how they bind to host cells may become a vital tool in the early control of winter vomiting disease and other virus-based diseases. In the west, this means saving money and reducing stress on health-care systems. In developing countries, this means saving lives.

28 Sep 2011

More predictability in the chaos of infectious Chagas disease transmission

Despite what Hollywood would have you believe, not all epidemics involve people suffering from zombie-like symptoms--some can only be uncovered through door-to-door epidemiology and advanced mathematics.

28 Sep 2011

Microbiologist offers advice to guard against coming down with the flu

October marks the beginning of flu season, and once again, health care professionals are exhorting people to get a flu shot. Microbiologist John Tudor, Ph.D., professor of biology at Saint Joseph's University in Philadelphia, agrees that it's time to roll up our sleeves and offer up our arms for the vaccination.

28 Sep 2011

Virus News and Research

Latest Virus News and Research

GeoVax completes enrollment for HIV/AIDS vaccine Phase 2a clinical trial

Bristol-Myers to present abstracts on research in liver disease at The Liver Meeting 2011

Viewpoints: Sebelius on improving care; Samuelson on health costs; Durenberger on exporting U.S. system

New analyses from Phase III studies of VICTRELIS to be presented at AASLD 2011

Vertex announces abstracts from hepatitis C program to be presented at The Liver Meeting

UCSF protein researcher wins NIH's Early Independence Award

Patients with chronic hepatitis C less likely to take medications over time

Researchers determine structure of RIG-I protein linked with viral infections

Small Phase I trial shows HIV vaccine candidate is most powerful to date

Powerful HIV vaccine being tested on humans

AASLD publishes updated practice guidelines on hepatitis C

Viewpoints: Blocking, replacing health law; a doc's HPV advice; County wellness plan working

Phase I clinical trials reveal MVA-B preventive vaccine's immune efficiency against HIV

Long-term morbidity and mortality of NAFLD patients with advanced fibrosis, cirrhosis

Anthrax defenses need to be strengthened: Experts

Vietnam closes kindergartens to control outbreak of hand, foot and mouth disease

Treatment of CMV infection can inhibit medullablastomas development

New method for quickly identifying individual viruses

More predictability in the chaos of infectious Chagas disease transmission

Microbiologist offers advice to guard against coming down with the flu

A new way of characterising biomolecules eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in